Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq

Cell chemical biology(2023)10.1016/j.chembiol.2022.12.005Source: DataRank Database

RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq is a research paper published in Cell chemical biology (2023). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

Linked data & code

geo gen uniprot doi

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 0.77)OA: bronzeTopics (43)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (12)

Lei Peng ORCID,Luojia Yang,Kazushi Suzuki ORCID,Zhenhao Fang ORCID,Paul Renauer ORCID

Live enrichment

PubMed:36640761 PMC:PMC9868106 OpenAlex:https://openalex.org/W4316036627

U.S. Department of Defense

Grant: W81XWH-20-1-0072

U.S. Department of Defense

Grant: W81XWH-21-1-0019

U.S. Department of Defense

Grant: W81XWH-21-1-0514

National Institute on Drug Abuse

Grant: DP2CA238295

National Institute on Drug Abuse

Grant: R01CA231112

NCI NIH HHS

Grant: R33 CA225498

National Cancer Institute

Pershing Square Sohn Cancer Research Alliance

National Institutes of Health

FWCI

0.77

Citation Percentile

0.7%

Citation Trend

2022

2023

2025

2026

bronzeLicense: http://www.elsevier.com/open-access/userlicense/1.0/

journalhttp://www.cell.com/article/S245194562200455X/pdf

publisherhttp://www.cell.com/article/S245194562200455X/pdf

publisherhttps://api.elsevier.com/content/article/PII:S245194562200455X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S245194562200455X?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.chembiol.2022.12.005

Fields of Study

Monoclonal and Polyclonal Antibodies ResearchSARS-CoV-2 and COVID-19 ResearchImmunotherapy and Immune ResponsesMiceHumansAnimalsAntibodies, MonoclonalRNA, MessengerImmunizationVaccinationAntibodies, NeutralizingMice, Transgenic

MeSH Terms

AnimalsAntibodies, MonoclonalHumansImmunizationMice, TransgenicRNA, MessengerVaccinationMiceAntibodies, Neutralizing

Keywords

Monoclonal antibodyImmunizationAntibodybreakpoint cluster regionHumanized mouseVirologyComputational biologyBiologyImmunologyGeneticsGeneImmune systemNeutralizing antibodymembrane proteinsCd22Covid-19Lnp-MrnaGprc5dOmicron VariantSingle-cell Bcr-seqRamihmFully Human Monoclonal Antibodies

Sustainable Development Goals

SDG 0: Good health and well-being

RAMIHM generates fully human monoclonal antibodies by rapid mRNA immunization of humanized mice and BCR-seq

FAIR Checklist

Authors (12)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)